Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

NCT02264743 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Venous Thrombosis
Insulin Resistance

Interventions

DRUG: Femoston Conti
DRUG: EVOREL® CONTI

Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Collaborators

[object Object]
[object Object]